- The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic. Omicron efficiently evades antibodies from infected or 2 x BNT vaccinated patients, but moderately evades antibodies induced by 3 x BNT or heterologous vaccination. https://www.cell.com/cell/fulltext/S0092-8674(21)01495-1?rss=yes&utm_source=dlvr.it&utm_medium=twitter 53 comments science
Linked pages
- https://www.samrc.ac.za/news/tshwane-district-omicron-variant-patient-profile-early-features 117 comments
- Adobe: Creative, marketing and document management solutions http://adobe.com 63 comments
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2107934 5 comments
- https://www.science.org/doi/10.1126/science.abm3425 5 comments
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034545 0 comments
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2114114 0 comments
- https://doi.org/10.1016/j.cell.2020.06.043 0 comments